Ziccum AB (publ) (ZICC.ST)

SEK 0.35

(-9.07%)

Total Debt Summary of Ziccum AB (publ)

  • Ziccum AB (publ)'s latest annual total debt in 2023 was 857 Thousand SEK , down -39.99% from previous year.
  • Ziccum AB (publ)'s latest quarterly total debt in 2024 Q2 was 571 Thousand SEK , down -20.03% from previous quarter.
  • Ziccum AB (publ) reported annual total debt of 1.42 Million SEK in 2022, down -28.6% from previous year.
  • Ziccum AB (publ) reported annual total debt of 2 Million SEK in 2021, down 0.0% from previous year.
  • Ziccum AB (publ) reported quarterly total debt of 429 Thousand SEK for 2024 Q3, down -24.87% from previous quarter.
  • Ziccum AB (publ) reported quarterly total debt of 571 Thousand SEK for 2024 Q2, down -20.03% from previous quarter.

Annual Total Debt Chart of Ziccum AB (publ) (2023 - 2017)

Historical Annual Total Debt of Ziccum AB (publ) (2023 - 2017)

Year Total Debt Total Debt Growth
2023 857 Thousand SEK -39.99%
2022 1.42 Million SEK -28.6%
2021 2 Million SEK 0.0%
2020 2 Million SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%

Peer Total Debt Comparison of Ziccum AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 94.676%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 82.788%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 96.5%
Genovis AB (publ.) 79.32 Million SEK 98.92%
Intervacc AB (publ) 181 Thousand SEK -373.481%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 95.842%
Active Biotech AB (publ) 3 Million SEK 71.433%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 98.579%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 82.86%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 98.8%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 89.052%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -102.123%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.211%
Karolinska Development AB (publ) 3.07 Million SEK 72.085%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 66.783%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 14.3%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.912%
Camurus AB (publ) 24.5 Million SEK 96.503%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 96.891%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.901%
Cyxone AB (publ) 858 Thousand SEK 0.117%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 49.912%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 97.672%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -28.679%
SynAct Pharma AB 637 Thousand SEK -34.537%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -0.824%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 51.334%
BioInvent International AB (publ) 23.24 Million SEK 96.313%
Alzinova AB (publ) 800 Thousand SEK -7.125%
Oncopeptides AB (publ) 106.48 Million SEK 99.195%
Pila Pharma AB (publ) 773.08 Thousand SEK -10.855%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.056%
Diamyd Medical AB (publ) 30.67 Million SEK 97.206%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.63%
Ascelia Pharma AB (publ) 1.06 Million SEK 19.227%
Diagonal Bio AB (publ) - SEK -Infinity%